DOXORUBIN is a chemotherapy agent used for the treatment of various types of cancer. Doxorubicin acts on tumor cells by disrupting their ability to divide and grow. This drug is used as part of combination therapy for cancer treatment, often in conjunction with other chemotherapy agents. It is administered intravenously and requires close medical monitoring
The product is used for:
Breast cancer
Non-small cell lung cancer
Ovarian cancer
Head and neck cancer
Treatment of other oncological diseases, as prescribed by a doctor
DOXORUBIN is administered intravenously, typically once every 3 weeks. The dosage is determined by the doctor based on the type of cancer and the patient's condition. The drug is infused slowly, and the dosage may be adjusted depending on the patient’s response to treatment and side effects. The treatment is conducted under the supervision of qualified healthcare professionals.
Contraindications:
Hypersensitivity to doxorubicin or other components of the product
Severe liver diseases
Severe bone marrow dysfunction
Pregnancy and breastfeeding (under medical supervision)
Active infections
Side Effects:
Nausea, vomiting
Decreased white blood cell count (leukopenia)
Loss of appetite
Hair loss (alopecia)
Fatigue, weakness
Liver dysfunction
Allergic reactions (rash, itching)
